Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Lapatinib | 10 | uM | 8 | 312.50 | 180.33 | 151.00 | 266.00 | 0.5677 | -0.2714 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 8 | 312.50 | 180.33 | 400.00 | 266.00 | 1.5038 | 3.1399 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 8 | 312.50 | 180.33 | 336.00 | 266.00 | 1.2632 | 2.0336 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 8 | 312.50 | 180.33 | 231.00 | 266.00 | 0.8684 | 0.5551 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 8 | 312.50 | 180.33 | 152.00 | 266.00 | 0.5714 | -0.2627 |
| SK-BR-3 | 0 | uM | 8 | 312.50 | 180.33 | 213.00 | 266.00 | 0.8008 | 0.3457 | |
| SK-BR-3 | 0 | uM | 8 | 312.50 | 180.33 | 188.00 | 266.00 | 0.7068 | 0.0771 | |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 566.00 | 773.00 | 0.7322 | 0.4682 | |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 752.00 | 773.00 | 0.9728 | 0.9461 | |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 603.00 | 773.00 | 0.7801 | 0.5634 | |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 625.00 | 384.25 | 767.00 | 773.00 | 0.9922 | 0.9846 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 8 | 625.00 | 384.25 | 797.00 | 773.00 | 1.0310 | 1.0616 |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 8 | 625.00 | 384.25 | 900.00 | 773.00 | 1.1643 | 1.3256 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 8 | 625.00 | 384.25 | 680.00 | 773.00 | 0.8797 | 0.7613 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 625.00 | 384.25 | 522.00 | 773.00 | 0.6753 | 0.3550 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 8 | 625.00 | 384.25 | 551.00 | 773.00 | 0.7128 | 0.4297 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 8 | 625.00 | 384.25 | 794.00 | 773.00 | 1.0272 | 1.0539 |
| SK-BR-3 | 0 | uM | 8 | 625.00 | 384.25 | 866.00 | 773.00 | 1.1203 | 1.2385 | |
| SK-BR-3 | 17-AAG | 0.1 | uM | 8 | 625.00 | 384.25 | 361.00 | 773.00 | 0.4670 | -0.0600 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 625.00 | 384.25 | 992.00 | 773.00 | 1.2833 | 1.5613 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 8 | 625.00 | 384.25 | 429.00 | 773.00 | 0.5550 | 0.1154 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 8 | 625.00 | 384.25 | 866.00 | 773.00 | 1.1203 | 1.2385 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 8 | 625.00 | 384.25 | 765.00 | 773.00 | 0.9897 | 0.9795 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 8 | 625.00 | 384.25 | 739.00 | 773.00 | 0.9560 | 0.9128 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 625.00 | 384.25 | 790.00 | 773.00 | 1.0220 | 1.0436 |